BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $561 from $535 and keeps a Buy rating on the shares. The MedTech tape has been up 3.2% since earnings season kicked off on October 15, the analyst tells investors in a research note. Following the U.S. election, BTIG believes devices, an area that generally gets bipartisan support, should be in a stronger relative position within the healthcare landscape under various scenarios.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules
- Workday initiated, Kraft Heinz downgraded: Wall Street’s top analyst calls
- Intuitive Surgical upgraded to Buy at Erste on ‘excellent market position’
- Intuitive Surgical upgraded to Buy from Hold at Erste Group
- Has Intuitive Surgical (NASDAQ:ISRG) Stock’s Valuation Gotten Out of Hand?
